Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 6 | 2021 | 278 | 2.510 |
Why?
|
| Dynamins | 6 | 2024 | 50 | 2.040 |
Why?
|
| Cardiopulmonary Resuscitation | 6 | 2024 | 222 | 1.730 |
Why?
|
| Myocardial Reperfusion Injury | 6 | 2024 | 58 | 1.710 |
Why?
|
| Mitochondrial Dynamics | 8 | 2024 | 56 | 1.690 |
Why?
|
| Emergency Medicine | 4 | 2024 | 125 | 1.510 |
Why?
|
| National Institutes of Health (U.S.) | 5 | 2024 | 125 | 1.330 |
Why?
|
| Community Health Services | 1 | 2023 | 82 | 0.800 |
Why?
|
| Mitochondrial Proteins | 4 | 2017 | 127 | 0.780 |
Why?
|
| Mitochondria, Heart | 6 | 2024 | 50 | 0.750 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 380 | 0.700 |
Why?
|
| Exercise | 1 | 2023 | 328 | 0.680 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 142 | 0.680 |
Why?
|
| Biomedical Research | 3 | 2024 | 405 | 0.680 |
Why?
|
| GTP Phosphohydrolases | 3 | 2015 | 74 | 0.670 |
Why?
|
| Hypothermia, Induced | 2 | 2017 | 82 | 0.630 |
Why?
|
| Myocytes, Cardiac | 7 | 2024 | 314 | 0.620 |
Why?
|
| Quinazolinones | 2 | 2015 | 15 | 0.600 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2017 | 13 | 0.590 |
Why?
|
| Dichloroacetic Acid | 1 | 2017 | 11 | 0.590 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 184 | 0.540 |
Why?
|
| Acute Generalized Exanthematous Pustulosis | 1 | 2015 | 1 | 0.510 |
Why?
|
| Emergency Service, Hospital | 4 | 2021 | 529 | 0.490 |
Why?
|
| Drug Eruptions | 1 | 2015 | 33 | 0.490 |
Why?
|
| Financing, Organized | 1 | 2015 | 12 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 3253 | 0.490 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 12 | 0.490 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2015 | 26 | 0.480 |
Why?
|
| Exanthema | 1 | 2015 | 40 | 0.470 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 111 | 0.460 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 90 | 0.460 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2014 | 3 | 0.460 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 78 | 0.460 |
Why?
|
| Mentors | 1 | 2015 | 90 | 0.450 |
Why?
|
| Mice | 11 | 2024 | 11859 | 0.440 |
Why?
|
| Animals | 25 | 2024 | 27537 | 0.440 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 490 | 0.410 |
Why?
|
| Vomiting | 1 | 2014 | 195 | 0.400 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 267 | 0.400 |
Why?
|
| Myocardium | 6 | 2015 | 573 | 0.380 |
Why?
|
| Doxorubicin | 3 | 2017 | 293 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 799 | 0.330 |
Why?
|
| Ductus Arteriosus | 2 | 2023 | 27 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 366 | 0.310 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 716 | 0.300 |
Why?
|
| Humans | 21 | 2024 | 90014 | 0.280 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2395 | 0.260 |
Why?
|
| Myofibrils | 6 | 1998 | 23 | 0.260 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 93 | 0.250 |
Why?
|
| Heart | 5 | 2023 | 578 | 0.240 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2015 | 136 | 0.230 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 25 | 0.230 |
Why?
|
| Calcium | 4 | 2024 | 1179 | 0.220 |
Why?
|
| Immunoblotting | 2 | 2015 | 272 | 0.220 |
Why?
|
| Cells, Cultured | 11 | 2017 | 2887 | 0.220 |
Why?
|
| Crime Victims | 1 | 2023 | 34 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 126 | 0.210 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 64 | 0.190 |
Why?
|
| Homeostasis | 1 | 2024 | 418 | 0.190 |
Why?
|
| Faculty | 1 | 2021 | 33 | 0.190 |
Why?
|
| Hydrogen Peroxide | 2 | 2020 | 158 | 0.190 |
Why?
|
| Heart Rate | 1 | 2024 | 498 | 0.190 |
Why?
|
| Violence | 1 | 2023 | 153 | 0.190 |
Why?
|
| Female | 12 | 2023 | 46618 | 0.180 |
Why?
|
| Microglia | 1 | 2021 | 108 | 0.180 |
Why?
|
| Tissue Distribution | 1 | 2021 | 293 | 0.180 |
Why?
|
| Mitochondria | 3 | 2020 | 556 | 0.180 |
Why?
|
| Altitude Sickness | 1 | 2020 | 12 | 0.180 |
Why?
|
| Myocardial Stunning | 1 | 2020 | 12 | 0.170 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 98 | 0.170 |
Why?
|
| Electron Transport Complex I | 1 | 2020 | 31 | 0.170 |
Why?
|
| Superoxides | 1 | 2020 | 74 | 0.170 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 198 | 0.170 |
Why?
|
| Sirtuin 3 | 2 | 2017 | 30 | 0.160 |
Why?
|
| Sepsis | 1 | 2023 | 329 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 338 | 0.160 |
Why?
|
| Random Allocation | 2 | 2020 | 327 | 0.160 |
Why?
|
| Myocardial Contraction | 5 | 1998 | 252 | 0.160 |
Why?
|
| Hospital Costs | 1 | 2019 | 109 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 341 | 0.150 |
Why?
|
| Glucose | 1 | 2021 | 629 | 0.150 |
Why?
|
| Oxygen | 3 | 2023 | 746 | 0.150 |
Why?
|
| Vasoconstriction | 2 | 2020 | 92 | 0.150 |
Why?
|
| Hemodynamics | 2 | 2020 | 738 | 0.150 |
Why?
|
| United States | 4 | 2024 | 7114 | 0.140 |
Why?
|
| Lignans | 1 | 2017 | 6 | 0.140 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 59 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 191 | 0.130 |
Why?
|
| Oxygen Consumption | 2 | 2013 | 245 | 0.130 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 11 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 189 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 145 | 0.120 |
Why?
|
| Mass Media | 1 | 2015 | 27 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.120 |
Why?
|
| Peristalsis | 1 | 2014 | 10 | 0.120 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 73 | 0.110 |
Why?
|
| Male | 7 | 2021 | 42706 | 0.110 |
Why?
|
| DNA Damage | 1 | 2016 | 374 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1704 | 0.110 |
Why?
|
| Abdomen | 1 | 2014 | 124 | 0.110 |
Why?
|
| Stomach | 1 | 2014 | 111 | 0.110 |
Why?
|
| Calcineurin Inhibitors | 1 | 2013 | 53 | 0.110 |
Why?
|
| Survival Rate | 1 | 2017 | 1899 | 0.110 |
Why?
|
| Rats | 8 | 2017 | 4048 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2014 | 284 | 0.100 |
Why?
|
| Tacrolimus | 1 | 2013 | 369 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 183 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 241 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2010 | 280 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 557 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2497 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 885 | 0.100 |
Why?
|
| Skin | 1 | 2015 | 589 | 0.090 |
Why?
|
| Flavanones | 1 | 2011 | 35 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 112 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2014 | 720 | 0.090 |
Why?
|
| Adult | 3 | 2021 | 26836 | 0.090 |
Why?
|
| Brain | 1 | 2021 | 2306 | 0.090 |
Why?
|
| Actins | 1 | 1993 | 462 | 0.090 |
Why?
|
| Child | 1 | 2021 | 7242 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 1237 | 0.080 |
Why?
|
| Proanthocyanidins | 1 | 2009 | 12 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 89 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 979 | 0.080 |
Why?
|
| Rabbits | 2 | 2023 | 640 | 0.070 |
Why?
|
| Myosin Heavy Chains | 2 | 1998 | 92 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1055 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2009 | 245 | 0.070 |
Why?
|
| Infant | 1 | 2014 | 3189 | 0.070 |
Why?
|
| Hypoxia | 2 | 2022 | 657 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 2013 | 524 | 0.060 |
Why?
|
| Cell Survival | 2 | 2022 | 983 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2013 | 1666 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 778 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2024 | 85 | 0.060 |
Why?
|
| Rotenone | 1 | 2023 | 18 | 0.050 |
Why?
|
| Electron Transport | 1 | 2023 | 74 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 50 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 91 | 0.050 |
Why?
|
| Middle Aged | 3 | 2019 | 26173 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2022 | 58 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 1998 | 2026 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 295 | 0.050 |
Why?
|
| Glycolysis | 1 | 2022 | 135 | 0.050 |
Why?
|
| Cannula | 1 | 2021 | 50 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 156 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2024 | 584 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 9237 | 0.040 |
Why?
|
| Lung | 2 | 2020 | 1292 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 5361 | 0.040 |
Why?
|
| Dyspnea | 1 | 2020 | 76 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2009 | 3404 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 144 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2011 | 1130 | 0.040 |
Why?
|
| Transcriptome | 1 | 2023 | 661 | 0.040 |
Why?
|
| Microtubules | 1 | 1998 | 123 | 0.040 |
Why?
|
| Vinculin | 1 | 1997 | 9 | 0.040 |
Why?
|
| Verapamil | 2 | 1997 | 34 | 0.040 |
Why?
|
| Integrin beta1 | 1 | 1997 | 33 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 182 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1670 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2016 | 21 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 467 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1997 | 426 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 28 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2016 | 25 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 1996 | 57 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2016 | 141 | 0.030 |
Why?
|
| Sirtuins | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2016 | 120 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 749 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 261 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 726 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2887 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 808 | 0.030 |
Why?
|
| Chloroquine | 1 | 1993 | 12 | 0.030 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2013 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 16 | 0.030 |
Why?
|
| Sarcomeres | 1 | 1993 | 27 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 137 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 55 | 0.030 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 65 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2016 | 458 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 759 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 82 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 140 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1993 | 436 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 29 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2011 | 63 | 0.020 |
Why?
|
| Scutellaria baicalensis | 1 | 2011 | 26 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 277 | 0.020 |
Why?
|
| Microscopy, Confocal | 3 | 1998 | 280 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 160 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2588 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2016 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 33 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 696 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 86 | 0.020 |
Why?
|
| Grape Seed Extract | 1 | 2009 | 4 | 0.020 |
Why?
|
| Vitis | 1 | 2009 | 19 | 0.020 |
Why?
|
| Protective Agents | 1 | 2009 | 34 | 0.020 |
Why?
|
| Seeds | 1 | 2009 | 51 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2009 | 230 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 126 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1718 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1227 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 1998 | 602 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 511 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 19272 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1997 | 56 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 313 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 72 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1998 | 285 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 401 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1996 | 72 | 0.010 |
Why?
|
| Transfection | 1 | 1997 | 909 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 563 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 389 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 26 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1995 | 91 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1997 | 677 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 1801 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1995 | 253 | 0.010 |
Why?
|